Showing results (231-240 of 639) with videos related to
Sort By:
Pageof 64
Cytokine|April 16, 2013
IL-6 and its receptors in coronary artery disease and acute myocardial infarctionDaniel R Anderson, Joseph T Poterucha, Ted R Mikuls, et al.Pharmacology & Therapeutics|October 19, 2019
Relevance of the antioxidant properties of methotrexate and doxycycline to their treatment of cardiovascular diseaseDahn L Clemens, Michael J Duryee, Johnathan H Hall, et al.Arthritis Care & Research|March 23, 2023
Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD-10-CM Diagnostic CodesAnthony Dolomisiewicz, Hanifah Ali, Punyasha Roul, et al.Arthritis Care & Research|November 1, 2023
Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following the Release of Safety DataStephanie Song, Bryant R England, Brian Sauer, et al.Journal of the American Medical Directors Association|September 19, 2006
Using a modified nominal group technique to elicit director of nursing input for an osteoporosis interventionDeborah A Levine, Kenneth G Saag, Linda L Casebeer, et al.Bone|January 12, 2010
Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronateRichard Eastell, Peiqi Chen, Kenneth G Saag, et al.Arthritis Care & Research|November 5, 2016
Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid ArthritisHuifeng Yun, Fenglong Xie, Randall N Beyl, et al.Clinical Therapeutics|May 28, 2014
Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviewsDawn M Odom, Deirdre M Mladsi, Kenneth G Saag, et al.The Annals of Pharmacotherapy|January 28, 2010
The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awarenessMichael J Miller, Michael R Schmitt, Jeroan J Allison, et al.Bone|June 26, 2026
Osteoporosis treatment adherence trajectories, comedication patterns, and romosozumab persistence among early users: A data-driven analysisYe Liu, Hongke Wu, Tarun Arora, et al.Pageof 64